Unitedhealth Expected to Post Higher Profit Amid Rate Hikes

Dow Jones
07/16
 

UnitedHealth is scheduled to report its second-quarter financial results before the market opens on Thursday. Here is what to know.

REVENUE: The country's biggest health insurance company is expected to report $110.79 billion in sales, compared with $111.62 billion in the previous second quarter, according to FactSet.

NET PROFIT: The Eden Prairie, Minn.-based company is expected to post a profit of $4.17 billion, compared with a profit of $3.41 billion the year before, according to FactSet.

ADJUSTED EARNINGS PER SHARE: Adjusted earnings are expected to come in at $4.88 a share, compared with $4.08 a share the prior year.

The stock has gained 26% this year, and recently traded at $424.

WHAT TO WATCH

- UnitedHealth is undergoing several strategic initiatives that position it well for growth ahead, Truist analysts. The analysts see the company's $1.5 billion investment in artificial intelligence this year as a way to drive operational efficiency, reduced friction, interoperability and better consumer experience.

- Elevance Health, another major health insurer, reported on Wednesday that membership fell, particularly in its Affordable Care Act and Medicaid plans. The company is exiting several Medicaid markets as government health insurance costs rise. Elevance, UnitedHealth and other insurers have also been raising ACA rates and plan to continue to do so next year, The Wall Street Journal reported.

- UnitedHealth's rate hikes have also improved its positioning with ACA plans, while membership is expected to shrink by a third, the Truist analysts say. Medicaid margins are expected to stay negative this fiscal year, but the analysts think they will improve in 2027 and beyond. They also see Medicare expanding margins in 2026, and think UnitedHealth's margins will recover overall across government-sponsored programs.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

July 15, 2026 12:18 ET (16:18 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10